Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-28T03:24:10.890Z Has data issue: false hasContentIssue false

Injury Criteria Associated with Soybean Exposure to Dicamba – CORRIGENDUM

Published online by Cambridge University Press:  26 September 2018

Rights & Permissions [Opens in a new window]

Abstract

Type
Corrigendum
Copyright
© Weed Science Society of America, 2018 

In the original publication of this article, there was a value missing from table 4. The incorrect and corrected copy are given below.

Incorrect copy:

Table 4 Leaf petiole droop and leaf petiole base swelling in soybean 7 and 15 d after treatment (DAT) with dicamba at V3/V4 and R1/R2.Footnote a

a Application timings: V3/V4 (third/fourth node with two to three fully expanded trifoliates) and R1/R2 (open flower at any node on main stem/open flower at one of the two uppermost nodes on main stem).

b Injury was visually rated using a scale of 0=no injury; 1= slight; 2=slight to moderate; 3= moderate; 4=moderate to severe; and 5=severe.

c Dicamba rates ranged from 1/1,000 to 1/2 of the use rate of 560 g ha-1.

d Means within each column followed by the same letter are not significantly different using Tukey-Kramer at P<0.05.

e Standard error of the mean in parentheses.

Correct copy:

Table 4 Leaf petiole droop and leaf petiole base swelling in soybean 7 and 15 d after treatment (DAT) with dicamba at V3/V4 and R1/R2.a

The authors regret this error.

Footnotes

Cite this article: Foster MR, Griffin JL (2018) Injury Criteria Associated with Soybean Exposure to Dicamba — Corrigendum. Weed Technol. doi: 10.1017/wet.2018.76

References

Foster, MR, Griffin, JL (2018) Injury Criteria Associated with Soybean Exposure to Dicamba. Weed Technol. doi: 10.1017/wet.2018.42 Google Scholar
Figure 0

Table 4 Leaf petiole droop and leaf petiole base swelling in soybean 7 and 15 d after treatment (DAT) with dicamba at V3/V4 and R1/R2.a

Figure 1

Table 4 Leaf petiole droop and leaf petiole base swelling in soybean 7 and 15 d after treatment (DAT) with dicamba at V3/V4 and R1/R2.a